发明名称 Alkyne substituted quinazoline compound and methods of use
摘要 The invention provides alkyne substituted quinazoline compounds, such as compounds of the formula (I), which are irreversible ErbB kinase inhibitors. The compounds are useful in the treatment of diseases and disorders where ErbB kinase activity is implicated such as a hyperproliferative disorder (
申请公布号 AU2012225693(A1) 申请公布日期 2013.09.19
申请号 AU20120225693 申请日期 2012.03.02
申请人 NEWGEN THERAPEUTICS, INC. 发明人 SHEN, WANG;ZHANG, AIMIN;MAUNG, JACK;ZHENG, XIAOLING
分类号 A61K31/517 主分类号 A61K31/517
代理机构 代理人
主权项
地址